Artificial Intelligence-assissted Glaucoma Evaluation
- Conditions
- Artificial IntelligenceGlaucoma
- Registration Number
- NCT03268031
- Lead Sponsor
- Sun Yat-sen University
- Brief Summary
Glaucoma is currently the second leading cause of irreversible blindness in the world. Our study intends to combine clinical data of glaucoma patients in Zhongshan Ophthalmic Center with Artificial Intelligence techniques to create programs that can screen and diagnose glaucoma.
- Detailed Description
Glaucoma is currently the second leading cause of irreversible blindness in the world, which brings heavy burden to human society. Compared to other ocular diseases, diagnostic process of glaucoma is complicated depends on multiple test results, including visual field test, OCT, etc. How to diagnose glaucoma correctly and fast has always been a hot topic in glaucoma researches. Artificial intelligence is used to study and develop theories and methods that can help simulate and extend human intelligence, which has been utilized in a lot of research fields such as automatic drive and medicine. The study intends to combine clinical data of glaucoma patients in Zhongshan Ophthalmic Center with Artificial Intelligence techniques to create programs that can screen and diagnose glaucoma.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10800
- BCVA>0.1
- able to complete reliable visual field test
- no history of intraocular surgery or fundus laser
- unable to complete visual field test
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Accuracy of diagnosis by artificial intelligence algorithm from August 2017 to February 2021 Accuracy of diagnosis by artificial intelligence algorithm and compare this result with glaucoma specialists
- Secondary Outcome Measures
Name Time Method Specificity of diagnosis by artificial intelligence algorithm from August 2017 to February 2021 Specificity of diagnosis by artificial intelligence algorithm
Sensitivity of diagnosis by artificial intelligence algorithm from August 2017 to February 2021 Sensitivity of diagnosis by artificial intelligence algorithm
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Zhongshan Ophthalmic Center
🇨🇳Guangzhou, Guangdong, China
Zhongshan Ophthalmic Center🇨🇳Guangzhou, Guangdong, China